TABLE 1.
Patient characteristics at baseline
| Characteristics | Values (n = 10) |
|---|---|
| Age, years | 61 (53, 72) |
| Male sex, n (%) | 6 (60%) |
| MELD score | 14 (9, 18) |
| Etiology of cirrhosis, n (%) | |
| Alcohol | 4 (40%) |
| NASH | 3 (30%) |
| NASH and alpha‐1 antitrypsin deficiency | 1 (10%) |
| Viral | 1 (10%) |
| Cryptogenic | 1 (10%) |
| Body mass index | 30.5 (21, 39) |
| Diabetes diagnosis, n (%) | 7 (70%) |
| Number of patients with OHE episode in prior 6 months, n (%) | 3 (30%) |
| TIPS in place, n (%) | 4 (40%) |
| Presence of ascites, n (%) | 7 (70%) |
| History of hepatocellular carcinoma, n (%) | 1 (10%) |
| Active on liver transplant waitlist, n (%) | 5 (50%) |
| Total bilirubin, mg/dL | 2.0 (1.4, 4.4) |
| Creatinine, mg/dL | 0.8 (0.50, 1.31) |
| International normalized ratio | 1.4 (1.1, 1.9) |
Data are presented as median (range) unless mentioned otherwise.
Abbreviations: MELD, Model for End‐Stage Liver Disease; NASH, nonalcoholic steatohepatitis; OHE, overt hepatic encephalopathy; TIPS, transjugular intrahepatic portosystemic shunt.